Not yet recruiting
Acute coronary syndrome
Not yet recruitingEarly LDL‑cholesterol reduction with rosuvastatin drug combination in patients with acute coronary syndrome
Registered drugNo placebo
Early LDL‑cholesterol reduction with rosuvastatin drug combination in patients with acute coronary syndrome
Registered drugNo placebo
- Disease:Acute coronary syndrome
- Substances:AlirocumabAtorvastatin+5
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Alirocumab
- Sponsor:Azienda Ospedaliera Universitaria Federico II Di Napoli
